ANI Pharmaceuticals, Inc. · NASDAQ:ANIP

Lalwani Nikhil sold 5,400 ANI Pharmaceuticals, Inc. shares (Form 4)

Traded Nov 16 to Nov 18, 2026 · Filed Nov 18, 2026

From Nov 16 to Nov 18, 2026, Lalwani Nikhil (Director, PRESIDENT & CEO) sold 5,400 ANI Pharmaceuticals, Inc. shares at an average US$71.22 for US$385K under a trading plan, leaving 328,289 shares. Filed Nov 18, 2026 (Form 4).

Sold
5,400 shares
Price
US$71.22 average (US$71.16 to US$71.40)
Value
US$385K
Holding after
328,289 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, PRESIDENT & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockSale1,318US$71.40332,371Direct
Nov 18, 2026Common StockSale4,082US$71.16328,289Direct

Source

Download original · View original at SEC

Related